What are the benefits and risks of different treatments that could delay or slow the progression of progressive multiple sclerosis?
Posted
Via Cochrane
What are the benefits and risks of different treatments that could delay or slow the progression of progressive multiple sclerosis? Key messages • Overall, we are very uncertain about the effects of treatments on relapses and slowing the worsening of disability. We did find evidence that rituximab after two years and interferon beta-1b after three years of treatment probably slightly reduce the number of people who experience relapses. • The number of people who stop taking a drug because of harmful events is slightly higher with interferon beta-1a, and probably slightly higher with...
